UNLABELLED: The small-large intestine axis in hydrogen sulfide accumulation and testing of sulfate and lactate in the gut-gut axis of the intestinal environment has not been well described. Sulfate reducing bacteria (SRB) of the Desulfovibrio genus reduce sulfate to hydrogen sulfide and can be involved in ulcerative colitis development. The background of the research was to find correlations between hydrogen sulfide production under the effect of an electron acceptor (sulfate) and donor (lactate) at different concentrations and Desulfovibrio piger Vib-7 growth, as well as their dissimilatory sulfate reduction in the intestinal small-large intestinal environment. METHODS: Microbiological, biochemical, and biophysical methods, and statistical processing of the results (principal component and cross-correlation analyses) were used. RESULTS: D. piger Vib-7 showed increased intensity of bacterial growth and hydrogen sulfide production under the following concentrations of sulfate and lactate: 17.4 mM and 35.6 mM, respectively. The study showed in what kind of intestinal environment D. piger Vib-7 grows at the highest level and produces the highest amount of hydrogen sulfide. CONCLUSIONS: The optimum intestinal environment of D. piger Vib-7 can serve as a good indicator of the occurrence of inflammatory bowel diseases; meaning that these findings can be broadly used in medicine practice dealing with the monitoring and diagnosis of intestinal ailments.

Department of Biomedical Sciences for Health University of Milan 20122 Milan Italy

Department of Experimental Biology Faculty of Science Masaryk University Kamenice 753 5 62500 Brno Czech Republic

Department of Human Pharmacology and Toxicology Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences 61242 Brno Czech Republic

Department of Plant Origin Foodstuffs Hygiene and Technology Faculty of Veterinary Hygiene and Ecology University of Veterinary and Pharmaceutical Sciences 61242 Brno Czech Republic

Zobrazit více v PubMed

Gibson G.R., Cummings J.H., Macfarlane G.T. Growth and activities of sulphate-reducing bacteria in gut contents of health subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 1991;86:103–112. doi: 10.1111/j.1574-6968.1991.tb04799.x. DOI

Gibson G.R., Macfarlane S., Macfarlane G.T. Metabolic interactions involving sulphate-reducing and methanogenic bacteria in the human large intestine. FEMS Microbiol. Ecol. 1993;12:117–125. doi: 10.1111/j.1574-6941.1993.tb00023.x. DOI

Cummings J.H., Macfarlane G.T., Macfarlane S. Intestinal Bacteria and Ulcerative Colitis. Curr. Issues Intest. Microbiol. 2003;4:9–20. PubMed

Barton L.L., Hamilton W.A. Sulphate-Reducing Bacteria Environmental and Engineered Systems. Cambridge University Press; Cambridge, UK: 2017.

Loubinoux J., Bronowicji J.P., Pereira I.A. Sulphate-reducing bacteria in human feces and their association with inflammatory diseases. FEMS Microbiol. Ecol. 2002;40:107–112. doi: 10.1111/j.1574-6941.2002.tb00942.x. PubMed DOI

Kováč J., Vítězová M., Kushkevych I. Metabolic activity of sulfate-reducing bacteria from rodents with colitis. Open Med. 2018;13:344–349. PubMed PMC

Kushkevych I., Vítězová M., Fedrová P., Vochyanová Z., Paráková L., Hošek J. Kinetic properties of growth of intestinal sulphate-reducing bacteria isolated from healthy mice and mice with ulcerative colitis. Acta Vet. Brno. 2017;86:405–411. doi: 10.2754/avb201786040405. DOI

Kushkevych I., Fafula R., Parak T., Bartoš M. Activity of Na+/K+-activated Mg2+-dependent ATP hydrolase in the cell-free extracts of the sulfate-reducing bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9. Acta Vet. Brno. 2015;84:3–12. doi: 10.2754/avb201585010003. DOI

Kushkevych I.V. Activity and kinetic properties of phosphotransacetylase from intestinal sulfate-reducing bacteria. Acta Biochem. Pol. 2015;62:1037–1108. doi: 10.18388/abp.2014_845. PubMed DOI

Kushkevych I.V. Kinetic Properties of Pyruvate Ferredoxin Oxidoreductase of Intestinal Sulfate-Reducing Bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9. Pol. J. Microbiol. 2015;64:107–114. PubMed

Loubinoux J., Mory F., Pereira I.A., Le Faou A.E. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J. Clin. Microbiol. 2000;38:931–934. PubMed PMC

Pitcher M.C., Cummings J.H. Hydrogen sulphide: A bacterial toxin in ulcerative colitis? Gut. 1996;39:1–4. doi: 10.1136/gut.39.1.1. PubMed DOI PMC

Florin T.H., Neale G., Goretski S. Sulfate in food and beverages. J. Food Compos. Anal. 1993;6:140–151. doi: 10.1006/jfca.1993.1016. DOI

Kushkevych I., Dordević D., Vítězová M., Kollár P. Cross-correlation analysis of the Desulfovibrio growth parameters of intestinal species isolated from people with colitis. Biologia. 2018;73:1137–1143. doi: 10.2478/s11756-018-0118-2. DOI

Kushkevych I., Dordević D., Vítězová M. Analysis of pH dose-dependent growth of sulfate-reducing bacteria. Open Med. 2019;14:66–74. doi: 10.1515/med-2019-0010. PubMed DOI PMC

Kushkevych I., Dordević D., Kollar P. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis. Open Life Sci. 2018;13:481–488. doi: 10.1515/biol-2018-0057. PubMed DOI PMC

Kushkevych I., Vítězová M., Kos J., Kollár P., Jampilek J. Effect of selected 8-hydroxyquinoline-2-carboxanilides on viability and sulfate metabolism of Desulfovibrio piger. J. Appl. Biomed. 2018;16:241–246. doi: 10.1016/j.jab.2018.01.004. DOI

Kushkevych I., Dordević D., Vítězová M. Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7. Arch. Microbiol. 2019;201:1–9. doi: 10.1007/s00203-019-01625-z. PubMed DOI

Kushkevych I., Kollar P., Suchy P., Parak T., Pauk K., Imramovsky A. Activity of selected salicylamides against intestinal sulfate-reducing bacteria. Neuroendocrinol. Lett. 2015;36:106–113. PubMed

Kushkevych I., Kollar P., Ferreira A.L., Palma D., Duarte A., Lopes M.M., Bartos M., Pauk K., Imramovsky A., Jampilek J. Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria. J. Appl. Biomed. 2016;14:125–130. doi: 10.1016/j.jab.2016.01.005. DOI

Kushkevych I., Kos J., Kollar P., Kralova K., Jampilek J. Activity of ring-substituted 8-hydroxyquinoline- 2-carboxanilides against intestinal sulfate-reducing bacteria Desulfovibrio piger. Med. Chem. Res. 2018;27:278–284. doi: 10.1007/s00044-017-2067-7. DOI

Loubinoux J., Valente F.M.A., Pereira I.A.C. Reclassification of the only species of the genus Desulfomonas, Desulfomonas pigra, as Desulfovibrio piger comb. nov. Int. J. Syst. Evol. Microbiol. 2002;52:1305–1308. PubMed

Postgate J.R. The Sulfate Reducing Bacteria. Cambridge University Press; Cambridge, UK: 1984.

Rowan F.E., Docherty N.G., Coffey J.C., O’Connell P.R. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br. J. Surg. 2009;96:151–158. doi: 10.1002/bjs.6454. PubMed DOI

Kushkevych I., Vítězová M., Vítěz T., Bartoš M. Production of biogas: Relationship between methanogenic and sulfate-reducing microorganisms. Open Life Sci. 2017;12:82–91. doi: 10.1515/biol-2017-0009. DOI

Kushkevych I., Vítězová M., Vítěz T., Kovac J., Kaucká P., Jesionek W., Bartoš M., Barton L. A new combination of substrates: Biogas production and diversity of the methanogenic microorganisms. Open Life Sci. 2018;13:119–128. doi: 10.1515/biol-2018-0017. PubMed DOI PMC

Kushkevych I., Kováč J., Vítězová M., Vítěz T., Bartoš M. The diversity of sulfate-reducing bacteria in the seven bioreactors. Arch. Microbiol. 2018;200:945–950. doi: 10.1007/s00203-018-1510-6. PubMed DOI

Černý M., Vítězová M., Vítěz T., Bartoš M., Kushkevych I. Variation in the Distribution of Hydrogen Producers from the Clostridiales Order in Biogas Reactors Depending on Different Input Substrates. Energies. 2018;11:3270.

Kováč J., Kushkevych I. New modification of cultivation medium for isolation and growth of intestinal sulfate-reducing bacteria; Proceedings of the International PhD Students Conference MendelNet; Brno, Czechia. 6–7 November 2019; pp. 702–707.

Kolmert A., Wikstrom P., Hallberg K.B. A fast and simple turbidimetric method for the determination of sulfate in sulfate-reducing bacterial cultures. J. Microbiol. Methods. 2000;41:179–184. doi: 10.1016/S0167-7012(00)00154-8. PubMed DOI

Cline J.D. Spectrophotometric determination of hydrogen sulfide in natural water. Limnol. Oceanogr. 1969;14:454–458. doi: 10.4319/lo.1969.14.3.0454. DOI

Bailey T.S., Pluth M.D. Chemiluminescent detection of enzymatically produced hydrogen sulfide: Substrate hydrogen bonding influences selectivity for H2S over biological thiols. J. Am. Chem. Soc. 2013;135:16697–16704. doi: 10.1021/ja408909h. PubMed DOI PMC

Bailey N.T.J. Statistical Methods in Biology. Cambridge University Press; Cambridge, UK: 1995.

Attene-Ramos M.S., Wagner E.D., Plewa M.J., Gaskins H.R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 2006;4:9–14. doi: 10.1158/1541-7786.MCR-05-0126. PubMed DOI

Beauchamp R.O., Bus J.S., Popp J.A., Boreiko C.J., Andjelkovich D.A., Leber P. A critical review of the literature on hydrogen sulfide toxicity. CRC Crit. Rev. Toxicol. 1984;13:25–97. doi: 10.3109/10408448409029321. PubMed DOI

Blachier F., Davila A.M., Mimoun S. Luminal sulfide and large intestine mucosa: Friend or foe? Amino Acids. 2010;39:335–347. doi: 10.1007/s00726-009-0445-2. PubMed DOI

Grieshaber M.K., Völkel S. Animal adaptations for tolerance and exploitation of poisonous sulfide. Annu. Rev. Physiol. 1998;60:33–53. doi: 10.1146/annurev.physiol.60.1.33. PubMed DOI

Advances in gut microbiota functions in inflammatory bowel disease: Dysbiosis, management, cytotoxicity assessment, and therapeutic perspectives

Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study

NADH and NADPH peroxidases as antioxidant defense mechanisms in intestinal sulfate-reducing bacteria

Sulfur content in foods and beverages and its role in human and animal metabolism: A scoping review of recent studies

Molecular Physiology of Anaerobic Phototrophic Purple and Green Sulfur Bacteria

Anoxygenic Photosynthesis in Photolithotrophic Sulfur Bacteria and Their Role in Detoxication of Hydrogen Sulfide

Microscopic Methods for Identification of Sulfate-Reducing Bacteria from Various Habitats

Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Colitis Studies

Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes

Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development

Sulfate-Reducing Bacteria of the Oral Cavity and Their Relation with Periodontitis-Recent Advances

Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People

Adenosine-5'-Phosphosulfate- and Sulfite Reductases Activities of Sulfate-Reducing Bacteria from Various Environments

The Characterization of Enterococcus Genus: Resistance Mechanisms and Inflammatory Bowel Disease

Recent Advances in Metabolic Pathways of Sulfate Reduction in Intestinal Bacteria

Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases

The Sulfate-Reducing Microbial Communities and Meta-Analysis of Their Occurrence during Diseases of Small-Large Intestine Axis